Both in Surgical Instruments
Tandem Diabetes Care vs NovoCure Limited
Over the past year TNDM returned +24.8% and NVCR returned +10.4%; their daily moves had a correlation of 0.10.
TNDM +24.8% NVCR +10.4%Growth of $1, one year, split-adjusted
| Metric | TNDM | NVCR |
|---|---|---|
| Price | $17.93 | $13.50 |
| Market cap | $1.25B | $1.58B |
| Today | −3.99% | +2.20% |
| 1 month | +8.5% | −11.2% |
| 6 months | −7.7% | −15.0% |
| Year to date | −18.4% | +4.4% |
| 1 year | +28.0% | +5.4% |
| Revenue growth (YoY) | +5.8% | +15.7% |
| Gross margin | 56.9% | 77.0% |
| Net margin | −8.3% | −5.4% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 2.2× |
| Net cash | -$146.6M | $267.1M |
| Dividend yield | — | — |
| Volatility (60d) | 50.5% | 46.9% |
| Short % of float | 21.9% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).